Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ionita, C. Cilt, C. Tudose, N. Bisca, A. Serbescu, D. Marta, D. Bumbacea, L. Cervis, R. Nemes, C. Teleaga, I. Balcu, I. P. Stoicescu (Bucharest, Romania). Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis. Eur Respir J 2008; 32: Suppl. 52, 586

Member's Comments

No comment yet.

Related content which might interest you: Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 Sarcoidosis relapses in corticosteroid treated patients Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 The clinical symptoms of newly diagnosed sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Occurrence of hypersensitivity to beryllium among patients with diagnosed sarcoidosis. Initial results Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Diagnosis and treatment of COPD patients who respond to steroids  Source: International Congress 2017 – State of the art session: "Airway diseases" Year: 2017 The features of patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 436s Year: 2002 Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Characteristics of the patients with sarcoidosis diagnosed by labial biopsy Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Prevalence of beryllium sensitization in patients diagnosed with sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Prediction of corticosteroid responder in newly diagnosed cardiac sarcoidosis patients with complete heart block Source: International Congress 2019 – Granulomatous disorders: from bench to bedside Year: 2019 Clinical features of patients with sarcoidosis associated with Sjogren‘s syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 32s Year: 2005 One year follow-up of patients with idiopathic pulmonary fibrosis treated with immunosuppressive therapy Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007 The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease Source: Eur Respir J 2005; 26: Suppl. 49, 331s Year: 2005 The features of sarcoidosis in owerweight patients. Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Patterns of resolution of acute severe asthma in children when treated with oral prednisolone Source: Eur Respir J 2001; 18: Suppl. 33, 122s Year: 2001